Impact of relative dose intensity of R-CCOP regimen in elderly patients with diffuse large B-cell lymphoma in China

Gao, H; Liu, Y; Xu, Y; Mi, L; Zhang, C; Wang, XP; Song, YQ; Zhu, J; Liu, WP

Zhu, J; Liu, WP (通讯作者),Peking Univ Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Dept Lymphoma, 52 Fucheng Rd, Beijing 100142, Peoples R China.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022; 121 (12): 2556

Abstract

Background: The actual relative dose intensity (RDI) of the attenuated R-CCOP regimen (rituximab, cytoxan, pegylated liposomal doxorubicin [PLD], vinc......

Full Text Link